CAFC News Brief

This case is about an appeal by DNA Genotek Inc. against a district court's ruling of non-infringement in a patent dispute with Spectrum Solutions LLC. The case revolves around U.S. Patent No. 10,619,187, which covers devices and methods for preserving nucleic acids. The core issue is the interpretation of the term "reagent compartment" within the patent's claims. The lower court construed this te...

Kroy IP Holdings, LLC sued Groupon, Inc. for patent infringement. Groupon moved to dismiss, arguing collateral estoppel based on prior Patent Trial and Appeal Board (PTAB) decisions finding other claims of the same patent unpatentable. The district court granted the motion, but the Federal Circuit reversed. The court found that the different burdens of proof between PTAB proceedings (preponderance...

In Trudell Medical International Inc. v. D R Burton Healthcare, LLC, the court reversed the district court's decision to admit expert testimony from a Dr. Collins due to procedural violations and unreliability. Consequently, the appeals court vacated the jury's finding of non-infringement and remanded the case for a new trial. Furthermore, the appellate court affirmed the denial of a judgment as a...

Regeneron Pharmaceuticals, holding patents for its drug EYLEA®, sued Samsung Bioepis and other companies for patent infringement after they filed applications to market biosimilars. The appeals court upheld the lower court's assertion of personal jurisdiction over Samsung Bioepis, a South Korean company, based on its nationwide marketing plans. The court also found that Regeneron demonstrated a li...

This non-precedential opinion from the United States Court of Appeals for the Federal Circuit affirms a preliminary injunction against Formycon AG, preventing it from marketing a biosimilar to Regeneron's EYLEA® without a license. The court upheld the lower court's finding of personal jurisdiction over Formycon, despite its arguments regarding its business operations outside of West Virginia. The...

This non-precedential Federal Circuit opinion affirms a district court's claim construction in a patent infringement case. Image Processing Technologies (IPT) appealed the district court's interpretation of a claim term in U.S. Patent No. 6,959,293, arguing it was broader than the broadest reasonable interpretation applied by the Patent Trial and Appeal Board (PTAB). The Federal Circuit disagreed,...

This is a non-precedential opinion from the United States Court of Appeals for the Federal Circuit affirming a district court's dismissal of a patent infringement lawsuit filed by Xiaohua Huang against Amazon. Huang alleged that Amazon infringed his patents on ternary content addressable memory technology through the use of EEPROM chips in various products. The district court dismissed Huang's com...

Steuben Foods sued Shibuya Hoppmann Corporation for infringing three of its patents related to aseptic food packaging. A jury found in favor of Steuben, awarding substantial damages. The District Court overturned the jury verdict via judgment as a matter of law (JMOL), granting a new trial conditionally. The Federal Circuit reversed the JMOL for two patents, reinstating the jury's verdict, and vac...

Deere & Company appealed a district court's denial of its post-trial motions for judgment as a matter of law (JMOL) and a new trial following a jury verdict finding no patent infringement against AGCO Corporation and Precision Planting, LLC. The dispute centered on Deere's patents for high-speed agricultural planting technology. The Federal Circuit affirmed the lower court's decisions, finding...

BearBox LLC sued Lancium LLC for patent infringement and conversion, alleging Lancium stole BearBox's Bitcoin mining technology. The District Court granted summary judgment to Lancium, finding the conversion claim preempted by federal patent law and that BearBox failed to prove Storms' inventorship of the disputed patent. The Federal Circuit affirmed, upholding the preemption ruling because the co...

This case centered on the validity of Novartis's patent for Entresto, a heart failure medication. The lower court found the patent invalid for lack of written description, but the appeals court reversed this decision, finding the patent adequately described the claimed invention. The appeals court upheld the lower court's findings that the patent claims were not obvious or lacking enablement. The...

This decision affirms a lower court's ruling that several Purdue Pharma patents related to OxyContin are invalid due to obviousness. The patents covered two aspects: a crush-resistant formulation and a process to reduce a potentially genotoxic impurity. The appeals court reviewed the lower court's findings on motivation to combine prior art, reasonable expectation of success, and secondary conside...

This case decision concerns a dispute between Teva and Amneal over Teva's listing of patents in the FDA's Orange Book, which impacts generic drug approvals. Amneal argued that Teva improperly listed patents relating to the inhaler device, not the active ingredient, delaying generic competition. The district court agreed, ordering Teva to delist the patents. The appeals court affirmed this decision...

In this trial court, Lone Star Technological Innovations sued Asus for inducing infringement of a patent related to color display technology. Asus appealed, raising several arguments including lack of standing, insufficient evidence of damages, and improper claim construction. The appeals court rejected all of Asus's arguments, finding that Lone Star had met its burden of proof and that substantia...

The Federal Circuit Court of Appeals affirmed a district court's judgment in a patent infringement case where Altria Client Services LLC successfully sued R.J. Reynolds Vapor Company for infringement of three patents related to electronic vapor devices. Reynolds appealed the jury verdict awarding Altria over $95 million in damages, challenging the infringement finding, the exclusion of certain inv...

The CAFC overturned a lower court ruling on a patent infringement case between CloudofChange, LLC and NCR Corporation. CloudofChange alleged that NCR's point-of-sale system, NCR Silver, infringed on their patents. The lower court found direct infringement, attributing the merchants' use of the system to NCR. The appeals court reversed, determining that NCR's merchants, not NCR itself, controlled a...

In Crown Packaging Technology, Inc. v. Belvac Production Machinery, Inc., the core issue is the validity of Crown's patents for necking machines, challenged by Belvac's claim that a pre-critical date offer for sale invalidated them under 35 U.S.C. § 102(b). The Federal Circuit reversed the lower court's decision, finding that Crown's letter to Complete Packaging Machinery constituted an invalidati...

This is a CAFC decision in the case of DDR Holdings, LLC v. Priceline.com LLC. The core issue is the proper claim construction of the terms "merchants" and "commerce object" within a patent related to e-commerce website design. The appeals court affirmed the district court's interpretation, holding that "merchants" refers only to purveyors of goods, not services, based on a significant omission in...

The CAFC affirms a lower court's decision to impose sanctions on PS Products, Inc. and its attorney for filing a frivolous design patent infringement lawsuit. The lower court awarded attorney fees and costs under 35 U.S.C. § 285 and additional deterrence sanctions under its inherent power. The appeals court upheld both awards, rejecting arguments that the sanctions were improperly imposed because...

Galderma Laboratories sued Lupin Inc. for patent infringement related to their respective doxycycline products. The lawsuit centered on whether Lupin's abbreviated new drug application (ANDA) infringed Galderma's patents. A district court found no infringement, a decision upheld by the Federal Circuit Court of Appeals. The appeals court agreed with the lower court's assessment of the presented evi...

Novartis Pharmaceuticals Corporation appealed a district court's denial of a preliminary injunction against MSN Pharmaceuticals, Inc., preventing the launch of MSN's generic version of Entresto. The dispute centered on whether MSN's product infringed Novartis's patent for an amorphous form of a compound. The district court found Novartis did not demonstrate a likelihood of success on the merits be...

This CAFC opinion concerns a patent infringement lawsuit filed by Mirror Worlds Technologies against Meta Platforms (formerly Facebook). Mirror Worlds claimed that Facebook's News Feed, Timeline, and Activity Log features infringed on their patents for chronologically organizing data on a computer system. The district court granted summary judgment to Meta, finding no infringement. The appeals cou...

The case is about DoggyPhone's patent infringement lawsuit against Tomofun. The lower court granted summary judgment to Tomofun, finding its "Furbo" device did not infringe DoggyPhone's patent for a remote pet communication system. The appellate court affirmed, focusing on the key claim limitation requiring transmission initiation in response to pet input. The court held that the Furbo's user-init...

This case is about Cellspin Soft, Inc.'s appeal of a district court's denial of its motion to recuse Judge Gonzalez Rogers and vacate summary judgment rulings in patent infringement cases against Fitbit and Nikon. The appeals court dismissed the appeal concerning Nikon due to procedural issues. Regarding Fitbit, the court affirmed the denial of the recusal motion, finding Cellspin's arguments unti...

The CAFC affirms a district court's grant of summary judgment for Fitbit, Nike, Under Armour, Fossil, Nikon, and Garmin in a patent infringement lawsuit brought by Cellspin Soft, Inc. Cellspin alleged infringement of three patents related to automatically uploading multimedia content via Bluetooth-enabled devices. The appeals court found that Cellspin failed to demonstrate a genuine dispute of mat...